Literature DB >> 2295880

Cellular basis of the proliferative response of human T cells to mouse xenoantigens.

B J Alter1, F H Bach.   

Abstract

Purified human T cells respond proliferatively to allogenic peripheral blood mononuclear (PBMC) stimulating cells but show no response to murine splenic stimulating cells. Two possible explanations for the lack of xenogeneic response are that human T cells, educated in a human thymus, cannot directly recognize a molecule as disparate as mouse antigen encoded by H-2 and/or that a cytokine(s) produced by the APCs is needed to allow a proliferative response and that the cytokine(s) produced by murine APC do not provide an adequate stimulus to the human T cells under these conditions. We show here that highly purified human T cells can respond directly in an antigen-specific manner to murine stimulating cells if human rIL-1 or rIL-2 or a T cell growth factor (TCGF) preparation are present in the culture. These findings demonstrate that human T cells can recognize murine antigens and that a highly significant response can be obtained if a human cytokine is present to permit that response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2295880      PMCID: PMC2187659          DOI: 10.1084/jem.171.1.333

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

Review 1.  Differential function of major histocompatibility complex antigens in T-lymphocyte activation.

Authors:  F H Bach; M L Bach; P M Sondel
Journal:  Nature       Date:  1976-01-29       Impact factor: 49.962

2.  Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response.

Authors:  B J Alter; F H Bach
Journal:  Cell Immunol       Date:  1970-07       Impact factor: 4.868

3.  Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.

Authors:  J Sprent; M Schaefer; D Lo; R Korngold
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

4.  Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses.

Authors:  H Golding; A Singer
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

5.  Self recognition of accessory cell Ia determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte responses.

Authors:  A M Kruisbeek; P M Andrysiak; A Singer
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

6.  HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes.

Authors:  M J Sheehy; P M Sondel; M L Bach; R Wank; F H Bach
Journal:  Science       Date:  1975-06-27       Impact factor: 47.728

Review 7.  LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytes.

Authors:  E Martz
Journal:  Hum Immunol       Date:  1987-01       Impact factor: 2.850

8.  Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2.

Authors:  M L Baroja; J L Ceuppens; J Van Damme; A Billiau
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

9.  Functional interactions of human and murine lymphoid cells. I. Analysis of primary and secondary responses.

Authors:  M Brunswick; P Lake
Journal:  Cell Immunol       Date:  1986-12       Impact factor: 4.868

10.  Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction.

Authors:  K F Lindahl; F H Bach
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Xenotransplantation--2000.

Authors:  M J Goddard; J E Foweraker; J Wallwork
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

Review 2.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes.

Authors:  A C Cunningham; T J Butler; J A Kirby
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

4.  Persistence of Indirect but Not Direct T Cell Xenoresponses in Baboon Recipients of Pig Cell and Organ Transplants.

Authors:  L Buhler; B M-W Illigens; O Nadazdin; A Tena; S Lee; D H Sachs; D K C Cooper; G Benichou
Journal:  Am J Transplant       Date:  2016-03-14       Impact factor: 8.086

5.  Antagonist effect of Interleukin 1 receptor on normal thymopoiesis and thymus toxicity of 5-azacytidine in mouse.

Authors:  Hongjing Yu; Mingyuan Wu; Bin Wen; Ningyun Sun; Di Xiang; Jing Zhang; Shunying Zhu; Shunyan Weng; Yan Yu; Wei Han
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

7.  CD4 T cells mediate cardiac xenograft rejection via host MHC Class II.

Authors:  Robert J Plenter; Todd J Grazia; An N Doan; Ronald G Gill; Biagio A Pietra
Journal:  J Heart Lung Transplant       Date:  2012-07-11       Impact factor: 10.247

8.  MRL/lpr-->severe combined immunodeficiency mouse allografts produce autoantibodies, acute graft-versus-host disease or a wasting syndrome depending on the source of cells.

Authors:  D Ashany; J J Hines; A E Gharavi; J Mouradian; J Drappa; K B Elkon
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

9.  Interaction of IL-1 beta, IL-6 and tumour necrosis factor-alpha (TNF-alpha) in human T cells activated by murine antigens.

Authors:  S Panzer; M Madden; K Matsuki
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

10.  Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease.

Authors:  John Wilson; Hannah Cullup; Rohan Lourie; Yonghua Sheng; Anna Palkova; Kristen J Radford; Anne M Dickinson; Alison M Rice; Derek N J Hart; David J Munster
Journal:  J Exp Med       Date:  2009-01-26       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.